Literature DB >> 19606394

Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis.

Mateja Legan1, Bostjan Luzar, Vera Ferlan Marolt.   

Abstract

OBJECTIVE: To investigate the angiogenic and prognostic role of cyclooxygenase-2 (COX-2) in gallbladder carcinomas. We assume COX-2 overexpression, neoangiogenesis and glucose transporter-1 (GLUT-1) to be involved in disease progression.
MATERIAL AND METHODS: The carcinoma tissues of 56 patients with gallbladder carcinomas were studied immunohistochemically for the expression of COX-2, GLUT-1 and micro-vessel density. The results were correlated with clinico-pathological features and survival/prognosis.
RESULTS: The overexpression of COX-2 in gallbladder carcinomas was significantly associated with increased angiogenesis and GLUT-1 expression. Neither angiogenesis nor the grade of the tumour correlate significantly with poor survival. Age, gender and a strong GLUT-1 expression were significant factors of adverse prognosis.
CONCLUSIONS: Next to age and gender of patients, hypoxia of gallbladder tumours is a factor influencing survival. Among hypoxic factors, GLUT-1 expression is an important (significant) denominator of poor prognosis in gallbladder carcinomas, but not COX-2 nor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19606394     DOI: 10.1080/00365520903121685

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Cyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomas.

Authors:  Mateja Legan
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

2.  Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary.

Authors:  Ja Seung Koo; Haeryoung Kim
Journal:  Tumour Biol       Date:  2011-05-20

3.  Glucose transporter-1 (GLUT-1) immunoreactivity in benign, premalignant and malignant lesions of the gallbladder.

Authors:  Mateja Legan; Spela Tevžič; Ana Tolar; Boštjan Luzar; Vera Ferlan Marolt
Journal:  Pathol Oncol Res       Date:  2010-05-29       Impact factor: 3.201

4.  Metabolic phenotypes in primary unknown metastatic carcinoma.

Authors:  Hye Min Kim; Do Hee Kim; Woo Hee Jung; Ja Seung Koo
Journal:  J Transl Med       Date:  2014-01-06       Impact factor: 5.531

5.  Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis.

Authors:  Zheng-Xiao Zhao; Lin-Wei Lu; Jian Qiu; Qiu-Ping Li; Fei Xu; Bao-Jun Liu; Jing-Cheng Dong; Wei-Yi Gong
Journal:  Oncotarget       Date:  2017-07-04

Review 6.  The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.

Authors:  Min Yu; Han Yongzhi; Shengying Chen; Xiaodan Luo; Ye Lin; Yu Zhou; Haosheng Jin; Baohua Hou; Yanying Deng; Lei Tu; Zhixiang Jian
Journal:  Oncotarget       Date:  2017-06-27

7.  Evaluation of P53, E-cadherin, Cox-2, and EGFR protein immunoexpression on prognostic of resected gallbladder carcinoma.

Authors:  Sergio Renato Pais-Costa; José Francisco de Matos Farah; Ricardo Artigiani-Neto; Sandro José Martins; Alberto Goldenberg
Journal:  Arq Bras Cir Dig       Date:  2014 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.